In pilot studies conducted on lab mice, the researchers utilized indocyanine green, a commonly used contrast agent approved by the Food and Drug Administration. When the agent is injected into the tumor, the cancerous cells glow when viewed with the glasses and a special light.
Achilefu, who also is co-leader of the Oncologic Imaging Program at Siteman Cancer Center and professor of biochemistry and molecular biophysics, is seeking FDA approval for a different molecular agent he's helping to develop for use with the glasses. This agent specifically targets and stays longer in cancer cells.
"This technology has great potential for patients and health-care professionals," Achilefu said. "Our goal is to make sure no cancer is left behind."
Dr. Achilefu has worked with Washington University's Office of Technology Management and has a patent pending for the technology.
The research is funded by the National Cancer Institute (R01CA171651) at the National Institutes of Health (NIH).
透过一副特制的高科技眼镜,医生小心切除闪着蓝光的癌变组织……当地时间2月10日,一台特殊的外科手术在美国密苏里州圣路易斯市一家医院里进行,借助这项刚刚问世的可视技术,原本几不可见的癌细胞变得无所遁形。
据美国媒体报道,这副能够“看见”癌细胞的眼镜由华盛顿大学
众所周知,即使置于高性能的显微镜下,癌细胞也难以被发现。但有了这副眼镜之后,医生能够轻松区分健康细胞和癌细胞,从而确保首次手术时不会遗漏任何癌变组织,进行二次切除手术以“查缺补漏”的可能性也由此大大降低。
【美学者发明可视眼镜 能清楚“看见”癌细胞】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15